Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | mitogen-activated protein kinase 3 | References | |
Homo sapiens | mitogen-activated protein kinase 1 | References |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 1 | 360 aa | 361 aa | 33.2 % |
Trypanosoma brucei | mitogen-activated protein kinase 5 | mitogen-activated protein kinase 3 | 357 aa | 316 aa | 34.5 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | mitogen activated protein kinase 3 | 0.0123 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0123 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0123 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0123 | 0.5 | 0.5 |
Loa Loa (eye worm) | CMGC/MAPK/ERK1 protein kinase | 0.0123 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0123 | 0.5 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase 3 | 0.0123 | 0.5 | 0.5 |
Trypanosoma brucei | mitogen activated protein kinase 4, putative | 0.0123 | 0.5 | 0.5 |
Echinococcus multilocularis | mitogen activated protein kinase | 0.0123 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen-activated protein kinase 11, putative | 0.0123 | 0.5 | 0.5 |
Trichomonas vaginalis | CMGC family protein kinase | 0.0123 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 4, putative | 0.0123 | 0.5 | 0.5 |
Toxoplasma gondii | CMGC kinase, MAPK family (ERK) MAPK-1 | 0.0123 | 0.5 | 0.5 |
Schistosoma mansoni | serine/threonine protein kinase | 0.0123 | 0.5 | 0.5 |
Echinococcus granulosus | mitogen activated protein kinase | 0.0123 | 0.5 | 0.5 |
Giardia lamblia | Kinase, CMGC MAPK | 0.0123 | 0.5 | 0.5 |
Trypanosoma brucei | protein kinase, putative | 0.0123 | 0.5 | 0.5 |
Leishmania major | mitogen activated protein kinase, putative,map kinase, putative | 0.0123 | 0.5 | 0.5 |
Leishmania major | mitogen activated protein kinase 4, putative;with=GeneDB:LmxM19.1440 | 0.0123 | 0.5 | 0.5 |
Trypanosoma cruzi | mitogen activated protein kinase 2, putative | 0.0123 | 0.5 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 15.6 nM | Inhibition of human recombinant GST-tagged ERK2 expressed in Escherichia coli using ser/thr 3 Peptide as substrate preincubated for 1 hr measured after 1 hr by Z-LYTE assay | ChEMBL. | 27106711 |
IC50 (binding) | = 66.9 nM | Inhibition of human recombinant GST-tagged ERK1 expressed in Escherichia coli using ser/thr 3 Peptide as substrate preincubated for 1 hr measured after 1 hr by Z-LYTE assay | ChEMBL. | 27106711 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.